New Treatment Available at Emory for the 850,000 U.S. Adults at Risk for Sudden Cardiac Arrest

New Treatment Cardiac Arrest RiskEmory University Hospital Midtown and Emory University Hospital in Atlanta are among the first hospitals nationwide and the only hospitals in Georgia to have access to the world’s first and only commercially available subcutaneous implantable defibrillator (S-ICD) for the treatment of patients at risk for sudden cardiac arrest (SCA).

Emory has been a part of the clinical trials to get this device approved and was the third highest enrolling center nationwide. Electrophysiologist Michael Lloyd, MD will be performing the procedure for the first time since the device has been approved on the open market on November 12, 2012.

The S-ICD System, produced by Boston Scientific, is designed to provide the same protection from SCA as transvenous implantable cardioverter defibrillators (ICDs); however the S-ICD System sits entirely just below the skin without the need for thin, insulated wires – known as electrodes or ‘leads’ – to be placed into the heart itself. This leaves the heart and blood vessels untouched, offering physicians and patients an alternative treatment to transvenous ICDs.

Sudden cardiac arrest is an abrupt loss of heart function. Most episodes are caused by the rapid and/or chaotic activity of the heart known as ventricular tachycardia or ventricular fibrillation. Recent estimates show that approximately 850,000 people in the United States are at risk of SCA and indicated for an ICD device, but remain unprotected.

Emory Electrophysiologists Mikhael El Chami, MD, Michael Hoskins, MD, Angel Leon, MD, David DeLurgio, MD, Jonathan Langberg, MD and Michael Lloyd, MD have been instrumental in getting this device approved and will be performing this procedure.

Dr. Michael LloydAbout Michael Lloyd, MD:
Dr. Lloyd began practicing medicine at Emory in 2007—he specializes in Cardiology and Cardiac Electrophysiology. His areas of clinical interest and research include arrhythmias, electrophysiology lab, and pacemaker. Dr. Lloyd’s organizational leadership memberships include the American College of Cardiology, the American Heart Association, and the Heart Rhythm Society.

 

Related Resources:

 

Tags: , , , , , ,

Comments are closed.